NovaBay Pharmaceuticals Contact Info NovaBay

New Post Public Reply Private Reply Replies (0) Message Board
crookedneck

NovaBay Pharmaceuticals Contact Info

NovaBay Pharmaceuticals, Inc.
5980 Horton Street, Suite 550
Emeryville, CA 94608
Office: (510) 899-8800
Fax: (510) 225-0371

View in a larger map

Contact us form

Corporate Inquiries:
Ron Najafi
Contact Ron
Scientific Inquiries:
Behzad Khosrovi
Contact Bez
Investor Relations Inquiries:
Thomas Paulson
Contact Tom
Business Development:
Roy J. Wu
Contact Roy


View NovaBay Pharmaceuticals, Inc. in a larger map.

Directions

BART:

NovaBay's facility is readily accessible by taking BART to MacArthur and then taking the Emery-Go-Round shuttle - Hollis route to stop #7, Horton & 59th Streets, “Amtrak Rail Station.” Shuttle buses leave the BART station every 10 or 15 minutes and the trip takes about 5 minutes.

From SFO/San Francisco:

  • 101 North to I-80 East (Bay Bridge)
  • Cross Bay Bridge. Keep toward LEFT after crossing bridge. Follow signs toward Berkeley.
  • Exit POWELL STREET, EXIT 9, EMERYVILLE
  • RIGHT onto POWELL STREET
  • Follow POWELL over the train tracks overpass; Make the first RIGHT onto PELADEAU STREET
  • RIGHT onto HARUFF STREET
  • RIGHT onto HORTON STREET/LANDREGAN STREET
  • 5980 HORTON STREET is on the RIGHT

(Note: the last 4 streets listed above are small side streets and easy to overlook.)

From Oakland Airport/San Jose Airport:

  • 880 North
  • From right lanes, take 980 East (toward Walnut Creek)
  • Keep to the RIGHT and take 580 West toward San Francisco
  • Keep to the RIGHT and Exit POWELL STREET, EXIT 9, EMERYVILLE
  • RIGHT onto POWELL STREET
  • Follow POWELL over the train tracks overpass; Make the first RIGHT onto PELADEAU STREET
  • RIGHT onto HARUFF STREET
  • RIGHT onto HORTON STREET/LANDREGAN STREET
  • 5980 HORTON STREET is on the RIGHT

(Note: the last 4 streets listed above are small side streets and easy to overlook.)

From Marin County:

  • Cross Richmond/San Rafael Bridge
  • 580 East, then 80 West toward San Francisco
  • Exit POWELL STREET, EMERYVILLE
  • LEFT onto FRONTAGE ROAD
  • LEFT ONTO POWELL STREET (go East)
  • Follow POWELL over the train tracks overpass; Make the first RIGHT onto PELADEAU STREET
  • RIGHT onto HARUFF STREET
  • RIGHT onto HORTON STREET/LANDREGAN STREET
  • 5980 HORTON STREET is on the RIGHT

(Note: the last 4 streets listed above are small side streets and easy to overlook.)

Parking:

  • Street parking is available, but limited. The AMTRAK public parking lot is on the left, across from the 5980 building. NovaBay offices: Suite 550, 5980 HORTON STREET.

Novabay Pharmaceuticals (NBY) Stock Research Links

NBY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles